Ysios Capital closes its third fund at €216 million ($260 million)

by Ysios Capital

​Ysios Capital, Spain’s largest and leading European venture capital firm specialised in the biotechnology sector, announces today that it has closed its third fund, Ysios BioFund III (YBF III) at...

Read more

ORYZON presents iadademstat ALICE 30-month data at EHA-2021, confirming positive and robust efficacy in combination with azacitidine in AML

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, presented today...

Read more

Un mapa de la expresión de los genes en el cerebro explica la muerte neuronal en la epilepsia

by Hospital de la Santa Creu i Sant Pau

Un trabajo publicado en Cell Reports descifra el mapa transcriptómico de la esclerosis del hipocampo, un hallazgo clave para el diagnóstico de la epilepsia del lóbulo temporal. Los resultados ident...

Read more

Pall Corporation Secures Multi-Million Dollar Contract With Exothera

by Pall Biotech

Manufacturing partnership enables suspension-based manufacture of gene therapies and viral vector-based vaccines

Read more

La spin off de la USC AFFINImeter, dentro del consorcio MOSBRI, consigue 5 millones de fondos europeos europeos

by BioIncubaTech

​La spin off de la Universidad de Santiago de Compostela, AFFINImeter, dentro de un consorcio con 13 universidades europeas y una multinacional británica para desarrollar una infraestructura de apo...

Read more

ORYZON reports results and corporate update for first half ended June 30, 2021

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported ...

Read more

HIGHLIGHTS: New investment milestone, a review of a historic and excepcional year, new health research center and more helps for entrepreneurs

by Biocat

The summer period has begun with some important news in the sector. Two of the most important biotech crowdfunding rounds of the year have been closed. And, Barcelona has announced the creation of a n...

Read more

Data orchestration startup Seqera Labs, span out from the CRG, raises $5.5 million in seed funding

by Centre for Genomic Regulation

Seqera Labs – the leading provider of data orchestration and workflow software for life sciences – announces it has raised $5.5 million USD in seed funding.

Read more

Algenex’ CrisBio® platform validated by EU and UK marketing authorization for CrisBio-based vaccine for Rabbit Viral Haemorrhagic Disease

by ALGENEX

​Algenex SL, a biotech company backed by Cleon Capital and Columbus Ventures delivering disruptive technologies for recombinant biologics production, and FATRO S.p.A, a leader in the field of veteri...

Read more

Flomics COVID19 NGS platform update

by Flomics Biotech SL

​Flomics Biotech continues to dedicate resources in the battle against the COVID19 pandemic. Last year Flomics announced the release of -FlomicsCOVID19– a cloud-based Next Generation Sequencing (N...

Read more

Gene variants associated to breast cancer

by Abyntek

​Breast cancer risk is determined by several factors and our genetic constellation can play a big part on it.

Read more

Ysios Capital’s portfolio company Aura Biosciences prices IPO on NASDAQ

by Ysios Capital

​Ysios Capital, a leading Spanish biotechnology venture capital firm, has announced that its portfolio company Aura Biosciences Inc. has priced its initial public offering (IPO) and is trading on th...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream